The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tonix Pharmaceuticals Holding Corp shares valued at $15,061 were purchased by Taylor Carolyn E. on Aug 21 ’25. At $36.03 per share, Taylor Carolyn E. acquired 418 shares. The insider’s holdings grew to 418 shares worth approximately $10332.96 following the completion of this transaction.
Also, Treco James purchased 250 shares, netting a total of over 9,000 in proceeds. Following the buying of shares at $36.00 each, the insider now holds 250 shares.
Before that, LEDERMAN SETH had added 4,000 shares to its account. In a trade valued at $86,200, the Chief Executive Officer bought Tonix Pharmaceuticals Holding Corp shares for $21.55 each. Upon closing the transaction, the insider’s holdings increased to 4,000 shares, worth approximately $99003.59999999999.
As published in their initiating research note from Noble Capital Markets on April 18, 2022, Tonix Pharmaceuticals Holding Corp [TNXP] has been an Outperform. Analysts at ROTH Capital upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid April. As of August 18, 2017, ROTH Capital has increased its “Neutral” rating to a “Buy” for TNXP. Earlier on September 07, 2016, ROTH Capital downgraded its rating. Their new recommendation was “a Neutral” for TNXP stock which previously was a “a Buy”.
Analyzing TNXP Stock Performance
On last trading session, Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] rose 3.22% to $24.72. The stock’s lowest price that day was $24.03, but it reached a high of $25.24 in the same session. During the last five days, there has been a surge of approximately 3.00%. Over the course of the year, Tonix Pharmaceuticals Holding Corp shares have jumped approximately 66.46%. Shares of the company reached a 52-week high of $69.97 on 08/14/25 and a 52-week low of $6.76 on 03/04/25.
Support And Resistance Levels for Tonix Pharmaceuticals Holding Corp (TNXP)
According to the 24-hour chart, there is a support level at 24.09, which, if violated, would cause prices to drop to 23.45. In the upper region, resistance lies at 25.30. The next price resistance is at 25.87. RSI (Relative Strength Index) is 38.73 on the 14-day chart, showing neutral technical sentiment.
Is Tonix Pharmaceuticals Holding Corp subject to short interest?
Stocks of Tonix Pharmaceuticals Holding Corp saw a sharp steep in short interest on 2025-09-15 dropping by 15557.0 shares to 1.33 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 1.35 million shares. A decline of -1.17% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.75 of the overall float, the days-to-cover ratio (short ratio) decline to 0.75.
